24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Beware of Hand Sanitizers Containing MethanolWhat Athletes Should Know About COVID-19, Heart Damage and Working OutCOVID-19 Causing More Stress in America Than Other Nations: SurveyWill Your Kid Play School Sports This Fall? Here's Some Guidance on Doing It SafelyScientists Call for Broader Use of Faster COVID TestsTwo Common Nutrients Might Keep Vertigo at BayPeople Are Dying, Going Blind After Drinking Hand Sanitizer, CDC WarnsMore Social Media Use, More Fake COVID NewsSkip the 'Maskne,' Not the MaskObesity Ups Odds for Severe COVID-19, But Age MattersSeven States Join Pact to Speed Coronavirus TestingStudy Casts Doubt on Value of Cholesterol DrugsCOVID-19 Fears Had Sick, Injured Americans Avoiding ERsCancer Diagnoses Plunge as Americans Avoid Screening During PandemicMysterious Paralyzing Illness in Kids Is Set to Return, CDC WarnsMany Older Americans Staying Strong in the PandemicCoronavirus Cases Now Climbing in the MidwestCould the First Drug That Slows Arthritis Be Here?Schools Can Reopen Safely If Precautions in Place, Australian Study ShowsFace Masks, Yes, But Don't Forget Hand-Washing TooEven With PPE, Risk of COVID-19 Still High for Frontline WorkersCoronavirus Pandemic Becoming Far More Widespread, Birx SaysGuard Against Lyme Disease This SummerKids 'Efficient' Transmitters as COVID-19 Raced Through a Georgia Summer CampCollege Students Will Need COVID Tests Every 2-3 Days for Campus Safety: StudyAHA News: Sustained High Blood Pressure May Damage Brain VesselsAnother Side Effect of COVID-19 -- Lasting Hearing Problems?Pandemic Could Complicate Hurricane SeasonStudy Reveals How Coronavirus Travels IndoorsNew Study Sheds Doubt on Notion Kids Aren't COVID-19 SpreadersAHA News: Are Virtual Doctor Visits Safe for Discharged Heart Failure Patients?Double Lung Transplants Save Lives of Sickest COVID PatientsGynecological Cancers Not a Risk for Severe COVID-19: Study11 States Could Face ICU Doc Shortages as Coronavirus Cases SurgeWildfire Pollution Puts Kidney Patients at RiskAmerica's Progress Against Early Cardiovascular Death Is SlowingAHA News: 5 Easy Ways to Keep Tabs on Heart HealthGene Study Shows How Coronavirus Swept Through the Diamond PrincessOne Disease Mosquitoes Don't Spread: CoronavirusU.S. Coronavirus Death Toll Surges Past 150,000Do Bedbugs Dirty the Air Inside Your Home?AHA News: New Test May Predict Who Develops Certain Type of Heart FailureLess Smoking, Drinking Means Fewer Hip Fractures for AmericansYet Another Study Finds Vaccines Are SafeCommon Diabetes Meds Linked to Higher Odds for a Serious ComplicationSurvivors' COVID Antibodies May Provide a Powerful GiftConcussion Ups Odds for Many Brain ConditionsFinal Coronavirus Vaccine Trials Get UnderwayAHA News: Flu Shot May Help Protect Vulnerable Hospital Patients From Heart Attack, Mini-StrokeCOVID-19 'Super Spreaders' Quickly Fill Room With Virus -- But Masks Help
Questions and AnswersLinks
Related Topics

Diabetes

Thyroid Drug May Not Help After Heart Attack: Study

HealthDay News
by -- E.J. Mundell
Updated: Jul 21st 2020

new article illustration

TUESDAY, July 21, 2020 (HealthDay News) -- If a heart attack survivor also has an underactive thyroid, treating them with supplemental thyroid hormone probably won't help, new research shows.

The study found that use of the hormonal drug, called levothyroxine, didn't improve heart muscle function in heart attack patients diagnosed with "subclinical hypothyroidism" -- an underactive thyroid.

In fact, "screening for and subsequent treatment of subclinical hypothyroidism in patients who have had a heart attack to preserve or improve heart function is not justified," concluded the study's lead author, Salman Razvi. He's a consultant endocrinologist at Newcastle University and the Queen Elizabeth Hospital in Gateshead, U.K.

Mild or subclinical hypothyroidism -- which affects about 10% of adults -- means that the thyroid doesn't produce enough hormones.

Management of the condition is uneven because there's a lack of good evidence either for or against treatment, Razvi's team noted.

Dr. Satjit Bhusri is a cardiologist at Lenox Hill Hospital in New York City. He wasn't involved in the new research but said that, in the United States, guidelines for heart patients "generally do not recommend checking thyroid function unless there is an indication that's related to an arrhythmia [irregular heartbeat]."

The new British study included 46 heart attack survivors who had received levothyroxine and 49 who received a "dummy" placebo.

A year into treatment, heart function had improved in both groups, the researchers said, but there was no greater improvement in those who'd received levothyroxine.

The findings suggest that levothyroxine does not improve heart function in patients who've had a heart attack and is unlikely to be beneficial, Razvi's group said.

"The results of this trial will help clinicians reconsider offering treatment with levothyroxine to tens of thousands of patients with subclinical hypothyroidism worldwide," Razvi said in a university news release.

"To any patient who has had a heart attack and has been diagnosed with subclinical hypothyroidism, I would advise that they consult their [doctor] on whether levothyroxine is likely to be of benefit," he added. "The results of our trial suggest that all such patients should have their thyroid function rechecked after a few weeks. Treatment with levothyroxine should not be started routinely in such patients."

Dr. Benjamin Hirsh directs preventive cardiology at Northwell Health's Sandra Atlas Bass Heart Hospital in Manhasset, N.Y. Reviewing the new findings, he noted that "subclinical hypothyroidism is a milder form of hypothyroidism that's more common than true primary hypothyroidism." According to Hirsh, subclinical hypothyroidism "affects approximately 5% of the population."

Hirsh said that the study appears to recommend against the use of levothyroxine in heart attack patients with subclinical hypothyroidism. However, he also believes that the study's methodology provided only a "narrow scope" in measuring the benefit of treatment for the heart.

Also, "the sample size of the study is quite small, and it is difficult to make a strong conclusion either way given this limitation," Hirsh said.

The study was published July 21 in the Journal of the American Medical Association.

More information

The U.S. National Library of Medicine has more on hypothyroidism.